Microbot’s LIBERTY system secures FDA approval for pivotal trial
Microbot is also working to engage additional medical centres for the trial. Credit: Dmitry Kalinovsky / Shutterstock. Pre-clinical medical device company Microbot Medical has obtained US Food and Drug Administration (FDA) approval to proceed with its pivotal human clinical trial for its LIBERTY robotic endovascular surgical system. The trial is a significant step in the […]
How global brands are perceived by top business leaders
Credit: Blue Planet Studio /Shutterstock How do top business decision makers regard the brands shaping the world’s biggest industries? GlobalData is conducting a comprehensive survey to help answer this question. Delving into respondents’ professional backgrounds, location, familiarity towards and experiences with major global organisations, the project seeks to provide a comprehensive overview of current market […]
Stryker to enhance orthopaedic portfolio with acquisition of Artelon
Stryker expects the acquisition to position itself more competitively in the foot and ankle segment. Credit: chayanuphol / Shutterstock. Medical technology company Stryker has agreed to acquire all issued and outstanding shares of Artelon, a privately held developer of soft tissue fixation products. The strategic move aims to bolster Stryker’s offerings in the soft tissue […]
BD to acquire Edwards Lifesciences’ Critical Care unit for $4.2bn
Edwards also plans to utilise the after-tax proceeds to explore new therapeutic areas for interventional heart failure. Credit: Peakstock / Shutterstock. BD (Becton, Dickinson and Company) has agreed to acquire the Critical Care product group from Edwards Lifesciences in an all-cash deal valued at $4.2bn. The Critical Care product group will continue to operate out […]
HighLife secures IDE to begin pivotal trial for TSMVR system
Functional mitral regurgitation is characterised when patients have blood that leaks back across the mitral valve despite having normal leaflet morphology. Image credit: Shutterstock / Sebastian Kaulitzki. The US Food and Drug Administration (FDA) has granted HighLife an investigational device exemption (IDE), greenlighting a pivotal trial investigating the French company’s trans-septal mitral valve replacement (TSMVR) […]
ASCO 2024: saliva test could ‘turn the tide’ on prostate cancer
The new saliva test sorts patients into groups by looking through the DNA in their samples for a range of small genetic changes linked to prostate cancer. Credit: Chinnapong / Shutterstock. Researchers of a study co-led by the Institute of Cancer Research (ICR) and the Royal Marsden National Health Service (NHS) Foundation Trust have shared […]
Massive Bio partners with Mika Health to expand oncology app
The partnership will see patients provided with free access to Mika Health’s software designed to address oncology-specific fatigue. Credit: Shutterstock / fizkes Artificial intelligence (AI) oncology firm, Massive Bio has teamed with the New York-based Mika Health to bring the latter’s oncology digital therapeutic to more patients in a bid to expand patient access to […]
ASCO 2024: Precede Biosciences assay classifies HER2 and ER status in cancers
Precede Bio’s liquid biopsy approach can measure epigenetic changes in cancer cells using just 1mL of plasma. Credit: Catalin Rusnac via Getty Images. Precede Biosciences has announced positive results for its novel liquid biopsy assay, which can classify human epidermal growth factor receptor 2 (HER2) status in multiple cancers and predict oestrogen receptor (ER) status, […]
FDA grants EUA for Watmind USA’s SpeedySwab Covid + FLU A&B
The SpeedySwab OTC test provides a quick method to determine the cause of their symptoms. Credit: Winterimages / Shutterstock. Watmind USA has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for its SpeedySwab Covid + FLU A&B Self-Test. This authorisation enables over-the-counter (OTC) and point-of-care (POC) use, offering a […]
Johnson & Johnson acquires Shockwave in $13.1bn deal
Shockwave’s IVL complements Johnson & Johnson’s positions in heart recovery and electrophysiology. Credit: Michael Vi / Shutterstock. Johnson & Johnson (J&J) has closed the acquisition of SS-based cardiovascular device developer Shockwave Medical. The deal between the parties was signed in April. As part of the deal, all Shockwave shares have been acquired by J&J for […]